| External factors: | Doxorubicin |
| Aging type: | Accelerate |
| Aging characteristic: |
| Category: | Chemical compounds |
| Phenotype: | Colorectal cancer |
| Experiment: | SA-β-gal activity assay//Flow cytometry |
| Description: | Activation of the DNA damage response (DDR) pathway was accompanied by the appearance of such markers of senescence as increased SA-β-Gal activity and cell cycle arrest. |
| Regulatory pathway: | -- |
| R-EF-Pathway: | -- |
| Pathway experiment: | -- |
| Pathway description: | -- |
Annotation: